Navigation Links
Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
Date:1/12/2010

BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Spherix Inc. (Nasdaq SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced the completion of patient enrollment in its global Phase 3 clinical trial NEET (70971-004), which is evaluating the safety and efficacy of D-tagatose as an oral treatment for Type 2 diabetes mellitus.  The company expects the efficacy results to be available as soon as mid-year, with the maintenance phase of the trial continuing through 2010.

Dr. Claire Kruger, Chief Executive Officer of Spherix commented, "This next year will potentially be the most exciting and gratifying time in our Company's history.  If successful and approved by the FDA, D-tagatose will offer a unique oral drug to improve glycemic control in Type 2 diabetes patients.  I am grateful for the hard work of our employees and contractors, which has allowed us to meet this significant milestone; however, much work remains to be done as we progress toward NDA filing."

The NEET (Naturlose (D-tagatose) Efficacy Evaluation Trial) is a global one-year, multi-center, placebo-controlled, double-blinded, randomized, parallel clinical study of 332 patients to evaluate the safety and effectiveness of D-tagatose on glycemic control in subjects with Type 2 diabetes under diet control and exercise.  The duration of the efficacy portion of the trial was reduced from twelve to six months in a protocol amendment submitted to the FDA last September.  The cardiovascular safety-testing portion of the trial totals twelve months.

In December 2008, after the initiation of the Phase 3 clinical trial by Spherix, the FDA issued a Guidance for Indust
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco
2. Spherix Reports Third Quarter 2009 Earnings
3. Spherix Announces Positive Phase 2 Study Results
4. Spherix Reports First Quarter 2009 Earnings
5. Spherix Elects New Independent Director, and Elects Chairman of the Board
6. Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data
7. Spherix Expands Phase 3 Naturlose Diabetes Trial Outside of the U.S.
8. Spherix D-tagatose to be Supplied by Inalco SpA
9. Growth Achieved in Spherixs Health Sciences Consulting Business
10. Spherix Reports Second Quarter Earnings
11. Dune Medical Completes Enrollment in MarginProbe(TM) Pivotal Trial for Real-Time Detection of Cancer During Breast Conservation Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... LONDON , March 27, 2015 ... commercial prospects for leading ophthalmic drug companies  ... the pharma ophthalmic industry ? Visiongain,s brand new ... trends, opportunities and prospects there. Our 242-page ... most lucrative areas in the industry and the future ...
(Date:3/27/2015)... DALLAS , March 27, 2015   ... global leader in biosimilars and the world,s leading ... two studies that support an evaluation of biosimilarity ... U.S. Food and Drug Administration (FDA) conditionally approved ... Amgen,s EPOGEN™ (epoetin alfa). These study data were ...
(Date:3/27/2015)... March 27, 2015 Concord Medical Services ... CCM ), a leading specialty hospital management ... of radiotherapy and diagnostic imaging centers in ... of a purchase agreement under which Concord Medical ... of the Company, agreed to acquire the Fortis ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3
... Nov. 12, 2010 Panasonic is proud to announce the ... Heart Day taking place on September 29. World Heart Day, ... 2000 and was created to inform people around the world ... the World Health Organization, heart disease and stroke are the ...
... Inc. (Nasdaq: VNDA ), announced today that it ... Financial Officer, Treasurer and Secretary of the Company. ... financial and operating roles within the healthcare and pharmaceutical industry, ... will join Vanda on December 13, 2010. "We ...
Cached Medicine Technology:Panasonic Sponsors 2011 World Heart Day 2Panasonic Sponsors 2011 World Heart Day 3Vanda Pharmaceuticals Appoints Chief Financial Officer 2
(Date:3/29/2015)... Clarkston, Metamora, MI. (PRWEB) March 29, 2015 ... Beaumont Hospital , offers comprehensive endometriosis treatment. Secondary ... in that area a closer hospital option. They ... Oakland and McLaren Oakland. , Endometriosis is ... lines the inside of the uterus (the endometrium) grows ...
(Date:3/29/2015)... March 29, 2015 The Claudia ... Women’s Cancer announce today that Dr. Beth Y. ... the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic ... Society of Gynecologic Oncology 46th Annual Meeting on Women's ... the Cedars-Sinai Women’s Cancer Program at the Samuel Oschin ...
(Date:3/29/2015)... 29, 2015 Youth Villages will participate ... Oregon to assess the feasibility of implementing a Pay ... behavioral problems and their families. , Third Sector Capital ... that will be provided technical assistance throughout 2015 toward ... six other national awardees chosen by Third Sector. The ...
(Date:3/28/2015)... 2015 Rocket Pure , a manufacturer ... release of their new natural sunscreen. They are offering ... Both options come with a bonus lip balm sunscreen. ... on Amazon. Click to see the natural sunscreen ... natural sunscreen is made with non-nano zinc oxide and provides ...
(Date:3/28/2015)... 2015 Take a bite of warm, ... action. Acids tumble into the stomach, ready to break ... structure lets these acids run amok, triggering a burning ... symptom. More than 60 million Americans have heartburn at ... heartburn starts, and how it can be stopped. , ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Endometriosis 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2
... who weigh less than five and a half pounds ... of medical complications, including respiratory problems. New research shows ... infancy and childhood and into adulthood. "We ... respiratory illnesses in young adults with a history of ...
... & Expo , , LITTLE ROCK, Ark., July ... recently announced its incoming President and Board in Phoenix, ... in June. Established in 1990, CMSA is an international ... and advancement of the case management profession. , ...
... 7 Nationally-known experts Claire Lavin, PhD, ... of helping those with intellectual disabilities face illness and ... online webinar on Tuesday, September 15, 2009, from 1pm-2pm ... have support to cope with normal grief reactions, and ...
... YORK, MONTREAL and SAN DIEGO, CA, July 7 /PRNewswire-FirstCall/ - ... (OTCPK: ICBT), and Ocular Therapeutics Inc. of San Diego California, ... of the largest pharmaceutical firms in the world. These unnamed ... largest of the ophthalmic markets. , , High Interest ...
... European Urology , the official journal of the European Association ... 6.512., This was announced in the Journal Citation Reports 2009, ... a respected urological forum for over 20 years and is ... Prof. Francesco Montorsi, Editor-in-Chief, points out. The Platinum ...
... NEUTROGENA(R), the #1 dermatologist recommended skincare brand, is proud ... grand-prize winner will win an exclusive trip for two ... Music VIP Event. At the Neutrogena Fresh Faces of ... to great music, have an opportunity to meet celebrity ...
Cached Medicine News:Health News:Low birth weight linked to long-term respiratory problems 2Health News:Low birth weight linked to long-term respiratory problems 3Health News:CMSA Announces Incoming President, Officers, and Directors 2Health News:CMSA Announces Incoming President, Officers, and Directors 3Health News:Hospice Foundation of America Presents New Educational Webinar on 'SUPPORTING PEOPLE WITH INTELLECTUAL DISABILITIES THROUGH ILLNESS, GRIEF AND LOSS' 2Health News:Hospice Foundation of America Presents New Educational Webinar on 'SUPPORTING PEOPLE WITH INTELLECTUAL DISABILITIES THROUGH ILLNESS, GRIEF AND LOSS' 3Health News:Major Firms Eyeing CBMS Development of New Glaucoma Treatment 2Health News:New impact factor of European Urology underlines journal's outstanding position 2Health News:NEUTROGENA(R) Announces Fresh Faces Sweepstakes 2
Family Practice: Letter Acuity, Astigmatic,Clock, Tumbling E, and Allen Tests....
Adult: Letter Acuity, Number Acuity, and Tumbling E Tests....
Acuity Astigmatism: Letter Acuity, Astigmatic Clock, Number Acuity, and Tumbling E Tests....
... is a serine protease that is,found only ... of the,acini and ducts. Normal PSA concentration ... Reports have suggested that elevated,level of whole ... useful tumor,markers in diagnosis of prostate cancers. ...
Medicine Products: